Filing Details

Accession Number:
0001274737-23-000008
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-10 16:08:38
Reporting Period:
2023-02-08
Accepted Time:
2023-02-10 16:08:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1274737 Exagen Inc. XGN Services-Medical Laboratories (8071) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1852986 Mark Hazeltine C/O Exagen Inc.
1261 Liberty Way
Vista CA 92081
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-02-08 5,821 $2.69 93,872 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 4, 2022.